Hill-Rom Holdings - 33 Year Stock Price History | HRC

Historical daily share price chart and data for Hill-Rom Holdings since 1987 adjusted for splits. The latest closing stock price for Hill-Rom Holdings as of May 26, 2020 is 98.91.
  • The all-time high Hill-Rom Holdings stock closing price was 116.34 on January 16, 2020.
  • The Hill-Rom Holdings 52-week high stock price is 117.50, which is 18.8% above the current share price.
  • The Hill-Rom Holdings 52-week low stock price is 72.29, which is 26.9% below the current share price.
  • The average Hill-Rom Holdings stock price for the last 52 weeks is 104.95.
Hill-Rom Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 104.8655 113.7400 116.3400 74.8800 98.9100 -12.88%
2019 103.2174 85.0300 114.0100 83.5800 113.5300 28.21%
2018 89.7918 84.6400 98.8500 79.7300 88.5500 5.05%
2017 74.3231 56.8400 85.3600 56.7600 84.2900 50.14%
2016 52.7120 47.1400 62.4500 43.2900 56.1400 16.81%
2015 51.2033 45.2700 57.7900 45.1300 48.0600 5.35%
2014 40.9842 40.9800 46.5100 35.1300 45.6200 10.35%
2013 35.9157 29.6000 42.2400 29.6000 41.3400 45.05%
2012 30.5271 34.2800 35.9600 25.3000 28.5000 -15.41%
2011 37.3400 39.8300 47.4800 27.3700 33.6900 -14.43%
2010 32.0370 24.4300 43.6200 23.3700 39.3700 64.11%
2009 17.0006 16.9500 24.1800 8.8900 23.9900 45.75%
2008 26.7492 29.8387 33.4600 15.6400 16.4600 -45.06%
2007 31.8820 30.4839 36.2849 28.0108 29.9624 -2.11%
2006 28.7452 26.6237 33.1129 25.4086 30.6075 15.22%
2005 27.5499 29.4624 30.5860 24.1935 26.5645 -11.04%
2004 31.5994 33.2581 37.7527 25.6452 29.8602 -10.51%
2003 28.5656 28.8011 33.3656 25.2204 33.3656 28.46%
2002 30.1816 29.5914 35.4785 25.2258 25.9731 -12.59%
2001 28.0723 27.6237 31.2366 23.5914 29.7151 7.32%
2000 19.6275 16.8333 29.9086 15.6237 27.6882 62.51%
1999 21.0981 29.8387 29.8387 14.1828 17.0376 -44.29%
1998 31.0729 27.1505 34.6129 26.0753 30.5806 11.12%
1997 23.5798 19.2903 27.5215 19.2903 27.5215 41.21%
1996 19.1341 18.2796 21.5054 17.2043 19.4892 6.99%
1995 16.0471 15.2581 18.2151 14.5860 18.2151 22.09%
1994 18.4549 22.3817 23.2527 14.4516 14.9194 -33.34%
1993 22.6914 21.3065 26.0753 19.6935 22.3817 5.39%
1992 20.7991 18.0108 23.3226 18.0108 21.2366 12.06%
1991 13.0438 10.3145 18.9516 10.1801 18.9516 85.53%
1990 11.0259 11.8952 12.9032 8.5027 10.2151 -13.14%
1989 9.2741 7.8952 11.9946 7.1586 11.7608 42.83%
1988 8.1872 6.6855 9.5780 6.3522 8.2339 23.76%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.659B $2.907B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $161.796B 28.06
Medtronic (MDT) Ireland $126.941B 20.64
Stryker (SYK) United States $69.021B 22.40
Boston Scientific (BSX) United States $50.251B 23.63
Baxter (BAX) United States $44.091B 26.91
Lonza Group Ag (LZAGY) Switzerland $37.041B 0.00
Terumo (TRUMY) Japan $28.057B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $26.322B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.470B 16.03
ResMed (RMD) United States $23.342B 36.84
Smith & Nephew SNATS (SNN) United Kingdom $17.880B 0.00
Sunny Optical Technology (SNPTF) China $15.213B 0.00
Bio-Rad Laboratories (BIO) United States $14.007B 63.76
Insulet (PODD) United States $12.117B 1200.50
DiaSorin S.p.A (DSRLF) Italy $10.937B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $7.417B 0.00
Perrigo (PRGO) Ireland $7.399B 13.24
Quidel (QDEL) United States $7.286B 57.26
Canopy Growth (CGC) Canada $6.813B 0.00
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
William Demant Holdings (WILYY) Denmark $6.417B 0.00
Haemonetics (HAE) United States $5.439B 32.67
ICU Medical (ICUI) United States $3.980B 29.03
GW Pharmaceuticals (GWPH) United Kingdom $3.925B 0.00
Agios Pharmaceuticals (AGIO) United States $3.636B 0.00
Neogen (NEOG) United States $3.523B 59.67
NuVasive (NUVA) United States $3.220B 25.86
Envista Holdings (NVST) United States $3.020B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.826B 0.00
TG Therapeutics (TGTX) United States $2.406B 0.00
National Vision Holdings (EYE) United States $2.037B 35.24
AtriCure (ATRC) United States $1.994B 0.00
Aurora Cannabis (ACB) Canada $1.624B 0.00
Cardiovascular Systems (CSII) United States $1.306B 0.00
MacroGenics (MGNX) United States $1.247B 0.00
NanoString Technologies (NSTG) United States $1.173B 0.00
Aphria (APHA) Canada $1.080B 0.00
Phibro Animal Health (PAHC) United States $1.001B 19.96
Cerus (CERS) United States $0.971B 0.00
OraSure Technologies (OSUR) United States $0.923B 185.88
InMode (INMD) Israel $0.838B 17.70
Omeros (OMER) United States $0.837B 0.00
PetIQ (PETQ) United States $0.818B 23.62
DFB Healthcare Acquisitions (AHCO) United States $0.756B 128.08
Eagle Pharmaceuticals (EGRX) United States $0.726B 52.03
VAREX IMAGING (VREX) United States $0.684B 16.99
Quanterix (QTRX) United States $0.681B 0.00
Meridian Bioscience (VIVO) United States $0.635B 23.92
Zynex (ZYXI) United States $0.631B 63.33
Vapotherm (VAPO) United States $0.557B 0.00
Surmodics (SRDX) United States $0.505B 60.88
Lantheus Holdings (LNTH) United States $0.505B 10.16
LeMaitre Vascular (LMAT) United States $0.503B 28.67
Owens & Minor (OMI) United States $0.463B 12.25
Repro-Med Systems (KRMD) United States $0.387B 325.00
Cytosorbents (CTSO) United States $0.378B 0.00
Utah Medical Products (UTMD) United States $0.333B 24.16
BioLife Solutions (BLFS) United States $0.328B 145.91
Viemed Healthcare (VMD) United States $0.323B 28.90
Neptune Wellness Solutions (NEPT) Canada $0.290B 0.00
Organigram Holdings (OGI) Canada $0.290B 0.00
HEXO (HEXO) $0.256B 0.00
Female Health (VERU) United States $0.241B 0.00
Chimerix (CMRX) United States $0.207B 0.00
Chembio Diagnostics (CEMI) United States $0.191B 0.00
Exagen (XGN) United States $0.175B 0.00
Bovie Medical (APYX) United States $0.157B 0.00
Evolus (EOLS) United States $0.151B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Fonar (FONR) United States $0.148B 13.08
Rockwell Medical (RMTI) United States $0.146B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.131B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
MTech Acquisition (KERN) United States $0.119B 0.00
Brainsway (BWAY) Israel $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.077B 0.00
Capricor Therapeutics (CAPR) United States $0.077B 0.00
Wound Management Technologies (SMTI) United States $0.076B 0.00
Nephros (NEPH) United States $0.070B 0.00
United-Guardian (UG) United States $0.069B 16.01
GUARDION HEALTH (GHSI) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.036B 0.00
ImmuCell (ICCC) United States $0.030B 0.00
NF Energy Saving (BIMI) China $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Senestech (SNES) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00